| Exosome as a novel shuttle for delivery of therapeutics across biological barriers CK Das, BC Jena, I Banerjee, S Das, A Parekh, SK Bhutia, M Mandal Molecular pharmaceutics 16 (1), 24-40, 2018 | 190 | 2018 |
| Pro-survival autophagy and cancer cell resistance to therapy CK Das, M Mandal, D Kögel Cancer and Metastasis Reviews 37, 749-766, 2018 | 151 | 2018 |
| Autophagy regulates cisplatin‐induced stemness and chemoresistance via the upregulation of CD 44, ABCB 1 and ADAM 17 in oral squamous cell carcinoma PP Naik, S Mukhopadhyay, PK Panda, N Sinha, CK Das, R Mishra, S Patil, ... Cell proliferation 51 (1), e12411, 2018 | 103 | 2018 |
| Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer CK Das, A Parekh, PK Parida, SK Bhutia, M Mandal Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1866 (6), 1004-1018, 2019 | 90 | 2019 |
| BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells CK Das, B Linder, F Bonn, F Rothweiler, I Dikic, M Michaelis, J Cinatl, ... Neoplasia 20 (3), 263-279, 2018 | 90 | 2018 |
| Lead bioactive compounds of Aloe vera as potential anticancer agent R Majumder, CK Das, M Mandal Pharmacological research 148, 104416, 2019 | 87 | 2019 |
| Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy R Bharti, G Dey, I Banerjee, KK Dey, S Parida, BNP Kumar, CK Das, I Pal, ... Cancer letters 388, 292-302, 2017 | 79 | 2017 |
| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 75 | 2018 |
| Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression BC Jena, CK Das, D Bharadwaj, M Mandal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (2), 188416, 2020 | 54 | 2020 |
| In vitro and in vivo antitumor effects of Peanut agglutinin through induction of apoptotic and autophagic cell death S Mukhopadhyay, PK Panda, B Behera, CK Das, MK Hassan, DN Das, ... Food and chemical toxicology 64, 369-377, 2014 | 54 | 2014 |
| Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer CK Das, I Banerjee, M Mandal Seminars in Cancer Biology 66, 59-74, 2020 | 45 | 2020 |
| S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ... Cancer gene therapy 23 (11), 382-391, 2016 | 36 | 2016 |
| Curcumin complexed with graphene derivative for breast cancer therapy D De, CK Das, D Mandal, M Mandal, N Pawar, A Chandra, AN Gupta ACS Applied Bio Materials 3 (9), 6284-6296, 2020 | 31 | 2020 |
| Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway BC Jena, CK Das, I Banerjee, S Das, D Bharadwaj, R Majumder, ... Biochemical Pharmacology 186, 114474, 2021 | 26 | 2021 |
| TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation BC Jena, CK Das, I Banerjee, D Bharadwaj, R Majumder, S Das, ... Experimental Cell Research 417 (1), 113195, 2022 | 21 | 2022 |
| Pre-clinical risk assessment and therapeutic potential of antitumor lipopeptide ‘Iturin A’in an in vivo and in vitro model G Dey, R Bharti, I Banerjee, AK Das, CK Das, S Das, BC Jena, M Misra, ... RSC advances 6 (75), 71612-71623, 2016 | 21 | 2016 |
| Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA R Majumder, CK Das, I Banerjee, BC Jena, A Mandal, P Das, AK Pradhan, ... Computers in Biology and Medicine 141, 105052, 2022 | 17 | 2022 |
| Natural products based nanoformulations for cancer treatment: current evolution in Indian research M Kundu, R Majumder, CK Das, M Mandal Biomedical Materials 16 (4), 044101, 2021 | 8 | 2021 |
| Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1 Q Deng, R Natesan, F Cidre-Aranaz, S Arif, Y Liu, R ur Rasool, P Wang, ... Cell reports 39 (11), 2022 | 7 | 2022 |
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance R Rasool, CM O’Connor, CK Das, M Alhusayan, BK Verma, S Islam, ... Nature Communications 14 (1), 5253, 2023 | 5 | 2023 |
